Stacie Dusetzina
LightNews LightNews
banner
dusetzinas.bsky.social
Stacie Dusetzina
@dusetzinas.bsky.social
3.2K followers 1K following 590 posts

Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.

Videos
Economics 71%
Public Health 8%
Posts Replies Media Videos

Reposted by Stacie B. Dusetzina

jsross119.bsky.social
Joseph Ross @jsross119.bsky.social · 15h
Lots more detail in the paper (jamanetwork.com/journals/jam...), but our findings provide the first evaluation of FDAAA and its enhanced safety-related regulatory authorities, and its impact on drug safety and public health, and informs current PDUFA VII negotiations! @reshmagar.bsky.social (5/5)
Postmarket Drug Safety−Related Actions Before and After the FDA Amendments Act
This cross-sectional analysis assesses whether the US Food and Drug Administration Amendments Act was associated with differences in time to first postmarket drug safety−related action and whether the...
jamanetwork.com

Reposted by Stacie B. Dusetzina

hollylynchez.bsky.social
Holly Fernandez Lynch @hollylynchez.bsky.social · 1d
Here, here.

"Congress must now also exercise its oversight responsibilities to ensure repairs to FDAs current and future capabilities, infrastructure, human resources, and reputation begin as soon as possible."

Big deal coming from investors/companies.

www.nopatientleftbehind.org/evidence-bas...
Supporting the Call for Evidence-Based Policy and Public Health Security — No Patient Left Behind
www.nopatientleftbehind.org

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 2d
Just a job where you were as hard as you can to cost your employer next to nothing?

Reposted by Stacie B. Dusetzina

sampat.bsky.social
Bhaven N. Sampat @sampat.bsky.social · 2d
Call open for an NBER conference on Medical Innovation Policy I'm co-organizing with @dusetzinas.bsky.social. Friday the 13th, naturally! Open to anyone (not just economists) working on the issues, and papers at different stages. www.nber.org/calls-papers...
Assessing the US Medical Innovation System Conference
www.nber.org

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 6d
Missed title opportunity of the decade.
vala.wtf sesbian lex fridman @vala.wtf · 6d
"capitol gains" was *right there*

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 6d
The news right now is horrifying. Why would anyone do this to people?

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 6d
Well, that graph is something else.
jakemgrumbach.bsky.social Jake Grumbach @jakemgrumbach.bsky.social · 6d
After becoming a congressional leader, a politician’s stock portfolio beats out those of peers by 47 (!!!) percentage points a year through trades timed around bills and firms that later get government contracts

www.nber.org/papers/w34524

via @florianederer.bsky.social
"Captain Gains" on Capitol Hill Shang-Jin Wei & Yifan Zhou WORKING PAPER 34524 DOI 10.3386/w34524 ISSUE DATE November 2025 Using transaction-level data on US congressional stock trades, we find that lawmakers who later ascend to leadership positions perform similarly to matched peers beforehand but outperform them by 47 percentage points annually after ascension. Leaders' superior performance arises through two mechanisms. The political influence channel is reflected in higher returns when their party controls the chamber, sales of stocks preceding regulatory actions, and purchase of stocks whose firms receiving more government contracts and favorable party support on bills. The corporate access channel is reflected in stock trades that predict subsequent corporate news and greater returns on donor-owned or home-state firms. 令 1 1 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 7 8 9 Year Figure 2: Estimated dynamic quasi-difference-in-differences coefficient, di, of equation(3), with vertical dashed lines representing 90 percent confidence intervals. The point estimate of the year in which the lawmaker became a congressional leader (Year 0) is normalized to zero. BHAR over the 250 days following each trade is the dependent variable and calculated using the Fama-French five-factor plus momentum as the benchmark model.

Reposted by Stacie B. Dusetzina

vala.wtf
sesbian lex fridman @vala.wtf · 6d
"capitol gains" was *right there*

Reposted by Archon Fung, Richard S.J. Tol, Nicholas A. Christakis , and 22 more

jakemgrumbach.bsky.social
Jake Grumbach @jakemgrumbach.bsky.social · 6d
After becoming a congressional leader, a politician’s stock portfolio beats out those of peers by 47 (!!!) percentage points a year through trades timed around bills and firms that later get government contracts

www.nber.org/papers/w34524

via @florianederer.bsky.social
"Captain Gains" on Capitol Hill Shang-Jin Wei & Yifan Zhou WORKING PAPER 34524 DOI 10.3386/w34524 ISSUE DATE November 2025 Using transaction-level data on US congressional stock trades, we find that lawmakers who later ascend to leadership positions perform similarly to matched peers beforehand but outperform them by 47 percentage points annually after ascension. Leaders' superior performance arises through two mechanisms. The political influence channel is reflected in higher returns when their party controls the chamber, sales of stocks preceding regulatory actions, and purchase of stocks whose firms receiving more government contracts and favorable party support on bills. The corporate access channel is reflected in stock trades that predict subsequent corporate news and greater returns on donor-owned or home-state firms. 令 1 1 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 7 8 9 Year Figure 2: Estimated dynamic quasi-difference-in-differences coefficient, di, of equation(3), with vertical dashed lines representing 90 percent confidence intervals. The point estimate of the year in which the lawmaker became a congressional leader (Year 0) is normalized to zero. BHAR over the 250 days following each trade is the dependent variable and calculated using the Fama-French five-factor plus momentum as the benchmark model.

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 6d
Yes. This is the map.

Reposted by Suresh Venkatasubramanian, Scott L. Greer, Stacie B. Dusetzina , and 13 more

clauirizarry.bsky.social
claudia irizarry aponte @clauirizarry.bsky.social · 6d
A 6-year-old boy is missing after ICE arrested him and his dad in NYC last week and shipped them off to separate facilities. www.thecity.nyc/2025/12/02/i... @thecity.nyc @gwynnefitz.bsky.social
ICE Arrested and Separated Chinese Father From 6-Year-Old Son, Advocates Say
The father and son were detained at an ICE check-in on Nov. 26, advocates say. The son’s location is currently unknown, while the father is being held at an upstate ICE facility.
www.thecity.nyc

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 14d
An auction full of Muppets and Jim Henson items you say? I have now identified the things in life I value and would spend a lot to own (that and my silly cats).

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 14d
Amazing! Science is so cool.
Hunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy share.google/POY4UXyNcBUL...
Hunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy
Oliver has an inherited condition called Hunter syndrome, which causes progressive damage to the body and brain.
share.google

Reposted by Stacie B. Dusetzina, Nathan P. Kalmoe

bakerdphd.bsky.social
Dominique Baker @bakerdphd.bsky.social · 16d
"Given that the Big Ten is about to create 'a for-profit company using what are essentially public dollars,' [a Penn State trustee] argued, boards need to know more in order to be able to advise their institutions accordingly."

www.insidehighered.com/news/governa...
Secretive Big Ten Deal Riles Trustees
The Big Ten is weighing a $2.4 billion private equity deal. But multiple trustees at member institutions say they aren’t getting enough information and the proposal has been rushed.
www.insidehighered.com

Reposted by Stacie B. Dusetzina

thewonkologist.bsky.social
Aaron Mitchell @thewonkologist.bsky.social · 18d
In good company alongside some cutting-edge basic science, our recent @bmj.com study examining the association between cancer drug profitability and utilization made the @mskcancercenter.bsky.social research highlights!
www.mskcc.org/news/msk-res...
@dusetzinas.bsky.social
MSK Research Highlights, November 20, 2025
New MSK research finds a potential therapeutic opportunity in regulatory T cells’ resilience to the loss of Foxp3; shows how cancer develops resistance to antibody-drug conjugates; develops a new syst...
www.mskcc.org

Reposted by Stacie B. Dusetzina, Christian E. Weller, David Darmofal

mallorymcmorrow.bsky.social
Mallory McMorrow @mallorymcmorrow.bsky.social · 20d
Michiganders are sharing their health insurance premiums increases with me… not 10% or 20%, but in one example - $200/month to $2900/month.

Republicans have tried to kill the ACA more than 70 times since 2010, and have never once had a plan for anything better.

Reposted by Stacie B. Dusetzina

wsj.com
The Wall Street Journal @wsj.com · 21d
Private Medicaid insurers list big networks of doctors to help get billions of taxpayer dollars. Many of those doctors don't actually see Medicaid patients.
Medicaid Insurers Promise Lots of Doctors. Good Luck Seeing One.
Many doctors listed in insurer networks treat few or no Medicaid recipients, leaving patients with long waits. “Don’t get sick.”
on.wsj.com

Reposted by Stacie B. Dusetzina

mcsweeneys.net
McSweeney's @mcsweeneys.net · 22d
"I realize there’s a lot going on right now between work and the seven-headed dragon that is here to brutally murder us, but I really need you to focus."
Don’t Let the Beasts from Revelation Distract You from Your Expense Reports
Thanks for coming in. Have a seat. I realize there’s a lot going on right now between work and the seven-headed dragon that is here to brutally mur...
buff.ly

Reposted by Stacie B. Dusetzina

frightaboutnow.com
Fright About Now 👻 Film Reviews @frightaboutnow.com · 23d
Sometimes, I kind of feel like a Frankenstein myself. Just a handful of mismatched limbs held together by vibes and one questionable thunderstorm.

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 24d
Wonderful! Congratulations!

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 24d
Sometimes I question my life decisions. Cheese judge would have been a good choice.

Reposted by Stacie B. Dusetzina

pbsnews.org
PBS News @pbsnews.org · 24d
Connoisseurs, culinary experts and curious consumers flocked to the three-day event in a country where cheese is both food and folklore. https://to.pbs.org/49lNcOW
More than 5,200 cheeses compete at the World Cheese Awards in Switzerland
Connoisseurs, culinary experts and curious consumers flocked to the three-day event in a country where cheese is both food and folklore.
www.pbs.org

Reposted by Ben C. Sheldon, Peter Thorne, Jesse M. Shapiro , and 2 more

jbyoder.org
Jeremy B. Yoder 🧬📊🌿🏳️‍🌈🖖🏻 @jbyoder.org · 24d
This has gotten surprisingly little attention — it's not even on the front page of @science.org right now — but it's really hard to describe what the SAFE Research Act would do to US science and scientists without sounding insane

www.science.org/content/arti...

Reposted by Stacie B. Dusetzina, Dana Howard

hollylynchez.bsky.social
Holly Fernandez Lynch @hollylynchez.bsky.social · 27d
“We can have an active, robust discussion as a group of medical experts spontaneously, and so we’re doing more of that,” Makary said of his preference for convening roundtables.

Guess what roundtables don't have? FACA requirements to occur in public with the opportunity for public comment.

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 27d
Excited to see this study out in the world! Looks at the counterfactual of a world in which biosimilars didn't launch. Always fun working with @thewonkologist.bsky.social
thewonkologist.bsky.social Aaron Mitchell @thewonkologist.bsky.social · 27d
Our new study is out today in @jamanetworkopen.com!
We looked at trends in biologic drug prices after biosimilar competition.

Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.

1/

jamanetwork.com/journals/jam...
Biologic Drug Prices in Medicare Part B After Entry of Biosimilars to the Market
This cohort study evaluates the associations of biosimilar entry to the market with the prices of originator biologics under Medicare Part B reimbursement.
jamanetwork.com

Reposted by Stacie B. Dusetzina

thewonkologist.bsky.social
Aaron Mitchell @thewonkologist.bsky.social · 27d
Our new study is out today in @jamanetworkopen.com!
We looked at trends in biologic drug prices after biosimilar competition.

Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.

1/

jamanetwork.com/journals/jam...
Biologic Drug Prices in Medicare Part B After Entry of Biosimilars to the Market
This cohort study evaluates the associations of biosimilar entry to the market with the prices of originator biologics under Medicare Part B reimbursement.
jamanetwork.com

dusetzinas.bsky.social
Stacie Dusetzina @dusetzinas.bsky.social · 28d
I could not love this more.

Reposted by Stacie B. Dusetzina

amnanawaz.bsky.social
Amna Nawaz @amnanawaz.bsky.social · 28d
How Bob Ross Inc is helping to close the public media funding gap

via @deema_zein

to.pbs.org/49Hzu96
Auction of Bob Ross paintings aims to fill funding gaps for public broadcasting
More than 30 years after his death, the work of artist and public television icon Bob Ross continues to engage audiences across the world. When Congress rescinded $1.1 billion allocated for public bro...
to.pbs.org

Reposted by Stacie B. Dusetzina, Julie Novkov, Olúfẹ́mi Táíwò

phillewis.bsky.social
Phil Lewis @phillewis.bsky.social · Nov 9
OutKast is inducted into the Rock & Roll Hall of Fame:

“We started in a little room. Great things start in little rooms”

Reposted by Jason Mittell, Michael Barnett, Michael S. Rosenberg , and 30 more

brittanytrang.com
Brittany Trang @brittanytrang.com · Nov 8
A Sharon Begley byline, almost 5 years after her death.

Upon hearing the news James Watson had died, a STAT reporter said in our Slack, "I wish I could read what Sharon would have written."

Incredible news: Sharon in fact did pre-write a Watson obit. And it is masterful and excoriating.
🧪🧬🧫
James Watson, dead at 97, was a scientific legend and a pariah among his peers
James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among his peers.
www.statnews.com